MediciNova Ptb Ratio from 2010 to 2024
| MNOV Stock | USD 1.34 0.01 0.75% |
PTB Ratio | First Reported 2010-12-31 | Previous Quarter 1.1794041 | Current Value 1.63 | Quarterly Volatility 1.7473735 |
Check MediciNova financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MediciNova's main balance sheet or income statement drivers, such as Interest Expense of 679.1 K, Other Operating Expenses of 14.5 M or Research Development of 7.9 M, as well as many indicators such as Price To Sales Ratio of 107, Dividend Yield of 0.0 or PTB Ratio of 1.63. MediciNova financial statements analysis is a perfect complement when working with MediciNova Valuation or Volatility modules.
MediciNova | Ptb Ratio |
Latest MediciNova's Ptb Ratio Growth Pattern
Below is the plot of the Ptb Ratio of MediciNova over the last few years. It is price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value. MediciNova's PTB Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in MediciNova's overall financial position and show how it may be relating to other accounts over time.
| Ptb Ratio | 10 Years Trend |
|
Ptb Ratio |
| Timeline |
MediciNova Ptb Ratio Regression Statistics
| Arithmetic Mean | 2.68 | |
| Geometric Mean | 1.93 | |
| Coefficient Of Variation | 65.23 | |
| Mean Deviation | 1.45 | |
| Median | 1.90 | |
| Standard Deviation | 1.75 | |
| Sample Variance | 3.05 | |
| Range | 5.8151 | |
| R-Value | 0.08 | |
| Mean Square Error | 3.27 | |
| R-Squared | 0.01 | |
| Significance | 0.77 | |
| Slope | 0.03 | |
| Total Sum of Squares | 42.75 |
MediciNova Ptb Ratio History
About MediciNova Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include MediciNova income statement, its balance sheet, and the statement of cash flows. MediciNova investors use historical funamental indicators, such as MediciNova's Ptb Ratio, to determine how well the company is positioned to perform in the future. Although MediciNova investors may use each financial statement separately, they are all related. The changes in MediciNova's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on MediciNova's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on MediciNova Financial Statements. Understanding these patterns can help to make the right decision on long term investment in MediciNova. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| PTB Ratio | 1.18 | 1.63 |
Pair Trading with MediciNova
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MediciNova position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MediciNova will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to MediciNova could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MediciNova when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MediciNova - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MediciNova to buy it.
The correlation of MediciNova is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MediciNova moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MediciNova moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MediciNova can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for MediciNova Stock Analysis
When running MediciNova's price analysis, check to measure MediciNova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MediciNova is operating at the current time. Most of MediciNova's value examination focuses on studying past and present price action to predict the probability of MediciNova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MediciNova's price. Additionally, you may evaluate how the addition of MediciNova to your portfolios can decrease your overall portfolio volatility.